NCT00254787View on ClinicalTrials.gov

Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

January 31, 2006

Conditions

Schizophrenia

Interventions

DRUG

IR (Immediate-Release) quetiapine fumarate (drug)

Trial Locations (6)

Unknown

Research Site, Berlin

Research Site, Cologne

Research Site, Essen

Research Site, Hamburg

Research Site, Jena

Research Site, Werneck

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY